Financial Statements — CRGO
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Cash & Equivalents | 19.98 | 21.00 | 9.29 |
| Total Current Assets | 43.82 | 55.45 | 68.89 |
| Goodwill | 15.34 | 15.63 | 15.63 |
| Total Non-current Assets | 27.81 | 26.71 | 28.32 |
| Total Assets | 71.64 | 82.15 | 97.21 |
| Total Current Liabilities | 20.37 | 15.98 | 13.99 |
| Total Non-current Liabilities | 2.50 | 1.87 | 5.43 |
| Total Liabilities* | 22.87 | 17.85 | 19.42 |
| Retained Earnings | (215.45) | (194.11) | (173.70) |
| Total Stockholder Equity | 48.77 | 64.31 | 77.78 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Total Revenue | 14.38 | 11.01 | 9.92 |
| Cost of Revenue* | 4.75 | 3.99 | 4.19 |
| Gross Profit | 9.63 | 7.02 | 5.73 |
| Research & Development | 5.91 | 4.90 | 6.01 |
| Selling, General & Admin | 5.38 | 5.34 | 6.08 |
| Total Operating Expenses | 18.83 | 17.07 | 69.59 |
| Operating Income | (9.19) | (10.05) | (63.87) |
| Pretax Income | (8.68) | (9.95) | (54.99) |
| Tax Provision | 0.09 | (0.02) | 0.00 |
| Net Income | (8.78) | (9.93) | (55.00) |
| Basic EPS | (0.18) | (0.21) | (1.33) |
| Diluted EPS | (0.18) | (0.21) | (1.33) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Operating Cash Flow | (2.53) | (4.50) | (18.81) |
| Investing Cash Flow | 11.94 | 5.51 | (51.47) |
| Financing Cash Flow | 0.19 | (0.11) | 73.27 |
